Iradimed

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$22,692
$21,202
$20,409
$19,510
Gross Profit
17,032
16,494
15,954
14,842
EBITDA
7,708
7,681
7,919
5,625
EBIT
7,094
7,297
7,327
5,431
Net Income
6,442
5,576
5,773
4,687
Net Change In Cash
22,692
21,202
20,409
19,510
Free Cash Flow
5,440
5,848
4,922
594
Cash
51,159
56,526
52,995
50,330
Basic Shares
12,875
12,860
12,830
12,825

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$83,814
$73,242
$65,562
$53,303
Gross Profit
64,324
56,349
50,158
41,282
EBITDA
28,527
22,782
20,035
16,298
EBIT
26,147
21,964
20,035
15,627
Net Income
22,480
19,234
17,192
12,827
Net Change In Cash
83,814
73,242
65,562
53,303
Cost of Revenue
-4,038
Free Cash Flow
17,182
17,619
5,457
8,167
Cash
51,159
52,233
49,762
57,960
Basic Shares
12,854
12,783
12,722
12,635

Earnings Calls

QuarterEPS
2025-12-31
$0.54
2025-09-30
$0.47
2025-06-30
$0.49
2025-03-31
$0.37